CellWell record HH-476727
Alternate-Day Recombinant FSH Dosing Is Non-Inferior to Daily Dosing for Controlled Ovarian Stimulation in Women with Normal Ovarian Reserve Undergoing IVF/ICSI
Shashank Sangoudar MS*
International Journal of Reproductive Research ยท 2026
In plain language
In a pilot randomized trial of 60 women undergoing IVF, alternate-day recombinant FSH used significantly less total gonadotropin than daily dosing while oocyte yield stayed similar.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-476727
Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.